PMC:7594251 / 1633-1729
Annnotations
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T11","span":{"begin":79,"end":83},"obj":"Chemical"}],"attributes":[{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"We also summarize the advantages and limitations of the primary NMR methods in drug development."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T15","span":{"begin":0,"end":96},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We also summarize the advantages and limitations of the primary NMR methods in drug development."}